Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Aleksandra Staniszewska, Frances Game, Jane Nixon, David Russell, David G Armstrong, Christopher Ashmore, Sicco A Bus, Jayer Chung, Vivienne Chuter, Ketan Dhatariya, George Dovell, Michael Edmonds, Robert Fitridge, Catherine Gooday, Emma J Hamilton, Amy Jones, Venu Kavarthapu, Lawrence A Lavery, Joseph L Mills, Matilde Monteiro-Soares, Maia Osborne-Grinter, Edgar J G Peters, Joseph Shalhoub, Jaap van Netten, Dane K Wukich, Robert J Hinchliffe
OBJECTIVE: Diabetes affects 537 million people globally, with 34% expected to develop foot ulceration in their lifetime. Diabetes-related foot ulceration causes strain on health care systems worldwide, necessitating provision of high-quality evidence to guide their management. Given heterogeneity of reported outcomes, a core outcome set (COS) was developed to standardize outcome measures in studies assessing treatments for diabetes-related foot ulceration. RESEARCH DESIGN AND METHODS: The COS was developed using Core Outcome Measures in Effectiveness Trials (COMET) methodology...
September 6, 2024: Diabetes Care
#2
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino, Kirstine J Bell, Rachel E J Besser, Ezio Bonifacio, Helen M Colhoun, Jennifer J Couper, Maria E Craig, Thomas Danne, Carine de Beaufort, Klemen Dovc, Kimberly A Driscoll, Sanjoy Dutta, Osagie Ebekozien, Helena Elding Larsson, Daniel J Feiten, Brigitte I Frohnert, Robert A Gabbay, Mary P Gallagher, Carla J Greenbaum, Kurt J Griffin, William Hagopian, Michael J Haller, Christel Hendrieckx, Emile Hendriks, Richard I G Holt, Lucille Hughes, Heba M Ismail, Laura M Jacobsen, Suzanne B Johnson, Leslie E Kolb, Olga Kordonouri, Karin Lange, Robert W Lash, Åke Lernmark, Ingrid Libman, Markus Lundgren, David M Maahs, M Loredana Marcovecchio, Chantal Mathieu, Kellee M Miller, Holly K O'Donnell, Tal Oron, Shivajirao P Patil, Rodica Pop-Busui, Marian J Rewers, Stephen S Rich, Desmond A Schatz, Rifka Schulman-Rosenbaum, Kimber M Simmons, Emily K Sims, Jay S Skyler, Laura B Smith, Cate Speake, Andrea K Steck, Nicholas P B Thomas, Ksenia N Tonyushkina, Riitta Veijola, John M Wentworth, Diane K Wherrett, Jamie R Wood, Anette-Gabriele Ziegler, Linda A DiMeglio
In the article cited above, incorrect affiliation information was given for author Linda A. DiMeglio. The correct affiliation for Linda A. DiMeglio is Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN. The online version of the article (https://doi.org/10.2337/dci24-0042) has been updated to correct the error.
September 6, 2024: Diabetes Care
#3
JOURNAL ARTICLE
Beth S Y Lim, Qian Yang, Mahesh Choolani, Daphne S L Gardner, Yap Seng Chong, Cuilin Zhang, Shiao-Yng Chan, Ling-Jun Li
OBJECTIVE: We explored the potential value of continuous glucose monitoring (CGM) in early pregnancy in predicting gestational diabetes mellitus (GDM) and pregnancy outcomes. RESEARCH DESIGN AND METHODS: The study recruited 103 multiethnic Asian pregnant women with overweight/obesity from a hospital-based, prospective cohort. All of them had worn blinded CGM devices in early pregnancy and underwent the universal GDM screening at 24-28 gestation weeks. Models were selected based on early pregnancy risk factors and CGM-derived parameters to compare their respective predictive values for GDM and pregnancy outcomes...
September 5, 2024: Diabetes Care
#4
JOURNAL ARTICLE
Meng Yang, Zhongqiang Cao, Wenqing Li, Jieqiong Zhou, Jiuying Liu, Yuanyuan Zhong, Yan Zhou, Lingli Sun, Ruizhen Li, Xiaonan Cai, Han Xiao, Aifen Zhou
OBJECTIVE: Gestational diabetes mellitus (GDM) is known to be associated with certain respiratory impairments in offspring. However, the specific association between maternal GDM and childhood lung function remains unclear. We examined the association of maternal glycemia, as measured by oral glucose tolerance test (OGTT) values, with childhood lung function outcomes in a birth cohort. RESEARCH DESIGN AND METHODS: A follow-up study was conducted with 889 children aged 6 years whose mothers underwent a 75-g OGTT between 24 and 28 weeks of gestation...
September 4, 2024: Diabetes Care
#5
LETTER
Steve R Noumegni, Arnaud D Kaze, Alain G Bertoni, Gregg C Fonarow, Justin B Echouffo-Tcheugui
No abstract text is available yet for this article.
September 4, 2024: Diabetes Care
#6
JOURNAL ARTICLE
Yoko Narasaki, Kamyar Kalantar-Zadeh, Andrea C Daza, Amy S You, Alejandra Novoa, Renal Amel Peralta, Man Kit Michael Siu, Danh V Nguyen, Connie M Rhee
OBJECTIVE: In the general population, continuous glucose monitoring (CGM) provides convenient and less-invasive glucose measurements than conventional self-monitored blood glucose and results in reduced hypo-/hyperglycemia and increased time-in-target glucose range. However, accuracy of CGM versus blood glucose is not well established in hemodialysis patients. RESEARCH DESIGN AND METHODS: Among 31 maintenance hemodialysis patients with diabetes hospitalized from October 2020-May 2021, we conducted protocolized glucose measurements using Dexcom G6 CGM versus blood glucose, with the latter measured before each meal and at night, plus every 30-min during hemodialysis...
August 30, 2024: Diabetes Care
#7
JOURNAL ARTICLE
Rachel Wong, Margaret A Hall, Talia Wiggen, Steven G Johnson, Jared D Huling, Lindsey E Turner, Kenneth J Wilkins, Hsin-Chieh Yeh, Til Stürmer, Carolyn T Bramante, John B Buse, Jane Reusch
OBJECTIVE: The coronavirus 2019 (COVID-19) pandemic has evolved over time by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, disease severity, treatment, and prevention. There is evidence of an elevated risk of incident diabetes after COVID-19; our objective was to evaluate whether this association is consistent across time and with contemporary viral variants. RESEARCH DESIGN AND METHODS: We conducted a retrospective cohort study using National COVID Cohort Collaborative (N3C) data to evaluate incident diabetes risk among COVID-positive adults compared with COVID-negative patients or control patients with acute respiratory illness (ARI)...
August 29, 2024: Diabetes Care
#8
JOURNAL ARTICLE
Patrick Divilly, Gilberte Martine-Edith, Natalie Zaremba, Uffe Søholm, Zeinab Mahmoudi, Monika Cigler, Namam Ali, Evertine J Abbink, Julie Brøsen, Bastiaan de Galan, Ulrik Pedersen-Bjergaard, Allan A Vaag, Rory J McCrimmon, Eric Renard, Simon Heller, Mark Evans, Julia K Mader, Stephanie A Amiel, Frans Pouwer, Pratik Choudhary
OBJECTIVE: Use of continuous glucose monitoring (CGM) has led to greater detection of hypoglycemia; the clinical significance of this is not fully understood. The Hypoglycaemia-Measurement, Thresholds and Impacts (Hypo-METRICS) study was designed to investigate the rates and duration of sensor-detected hypoglycemia (SDH) and their relationship with person-reported hypoglycemia (PRH) in people living with type 1 diabetes (T1D) and insulin-treated type 2 diabetes (T2D) with prior experience of hypoglycemia...
August 29, 2024: Diabetes Care
#9
JOURNAL ARTICLE
Abigail Dove, Jiao Wang, Huijie Huang, Michelle M Dunk, Sakura Sakakibara, Marc Guitart-Masip, Goran Papenberg, Weili Xu
OBJECTIVE: Diabetes is a well-known risk factor for dementia. We investigated the association between (pre)diabetes and older brain age and whether this can be attenuated by modifiable lifestyle behaviors. RESEARCH DESIGN AND METHODS: The study included 31,229 dementia-free adults from the UK Biobank between the ages of 40 and 70. Glycemic status (normoglycemia, prediabetes, or diabetes) was ascertained based on medical history, medication use, and HbA1c measured at baseline...
August 28, 2024: Diabetes Care
#10
JOURNAL ARTICLE
Ariane Jullien, Clément Jambon-Barbara, Jean-Luc Cracowski, Brian L Claggett, Anne-Laure Borel, Charles Khouri, Matthieu Roustit
OBJECTIVE: Multiregional trials are designed under the assumption that treatment effect applies to the entire target population, yet several factors may introduce geographic heterogeneity in treatment effect. We explored whether such variations exist in trials assessing the efficacy of glucagon-like peptide 1 receptor agonists (GLP-1RAs) in major cardiovascular events (MACE) in type 2 diabetes. RESEARCH DESIGN AND METHODS: A systematic search of Medline and the Cochrane Library was conducted from inception until 30 June 2020...
August 27, 2024: Diabetes Care
#11
JOURNAL ARTICLE
Johanna Hammersen, Sascha R Tittel, Clemens Kamrath, Katharina Warncke, Angela Galler, Ulrike Menzel, Melanie Hess, Thomas Meißner, Beate Karges, Reinhard W Holl
OBJECTIVE: This study was conducted to evaluate the effects of early clinical diagnosis of type 1 diabetes by comparison of clinical parameters at diagnosis and during follow-up in patients with pediatric type 1 diabetes with early, intermediate, and late diagnosis. RESEARCH DESIGN AND METHODS: In a population-based analysis, data on 14,292 pediatric patients with type 1 diabetes diagnosed between 2015 and 2019 were retrieved from the Diabetes Prospective Documentation (DPV) registry in March 2023...
August 26, 2024: Diabetes Care
#12
JOURNAL ARTICLE
Antoine Christiaens, Anne-Sophie Boureau, Béatrice Guyomarch, Laure de Decker, Benoit Boland, Samy Hadjadj, Bertrand Cariou
OBJECTIVE: To assess the accuracy of "diabetes overtreatment" proxy definitions in predicting hypoglycemia in older adults with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: Inclusion of patients from HYPOAGE cohort with insulin-treated T2D, aged ≥75 years, and using a continuous glycemic monitoring (CGM) device for 28 days. "Diabetes overtreatment" was defined as HbA1c < 7.0% (fixed proxy definition) or as HbA1c < 7.0%, 7.5% and 8.0% according to patient's health status (individualized proxy definition)...
August 22, 2024: Diabetes Care
#13
LETTER
Alessandra Corrado, Giuseppe Scidà, Jumana Abuqwider, Carmen Rainone, Roberta Lupoli, Maria Masulli, Lutgarda Bozzetto, Giovanni Annuzzi
No abstract text is available yet for this article.
August 20, 2024: Diabetes Care
#14
LETTER
Mark Germaine, Graham Healy, Brendan Egan
No abstract text is available yet for this article.
August 19, 2024: Diabetes Care
#15
JOURNAL ARTICLE
Ming Yeh Lee, Susan M Seav, Loice Ongwela, Julie J Lee, Rachel Aubyrn, Fang Y Cao, Anna Kalinsky, Olivia Aparicio Ramos, Yunzi Gu, Kailee Kingston, Maja Ivanovic, Bruce A Buckingham, Dimpi Desai, Rayhan A Lal, Marilyn Tan, Marina Basina, Michael S Hughes
OBJECTIVE: We aimed to assess the feasibility, clinical accuracy, and acceptance of a hospital-wide continuous glucose monitoring (CGM) policy with electronic health record (EHR)-integrated validation for insulin dosing. RESEARCH DESIGN AND METHODS: A hospital policy was developed and implemented at Stanford Health Care for using personal CGMs in lieu of fingerstick blood glucose (FSBG) monitoring. It included requirements specific to each CGM, accuracy monitoring protocols, and EHR integration...
August 14, 2024: Diabetes Care
#16
JOURNAL ARTICLE
Tae-Min Rhee, Jaewon Choi, Hyunsuk Lee, Jordi Merino, Jun-Bean Park, Soo Heon Kwak
OBJECTIVE: Obesity is a key predictor of type 2 diabetes (T2D). However, metabolic complications are not solely due to increased BMI. We hypothesized that differences between genetically predicted BMI and observed BMI (BMI-diff) could reflect deviation from individual set point and may predict incident T2D. RESEARCH DESIGN AND METHODS: From the UK Biobank cohort, we selected participants of European ancestry without T2D (n = 332,154). The polygenic risk score for BMI was calculated via Bayesian regression and continuous shrinkage priors (PRS-CS)...
August 13, 2024: Diabetes Care
#17
JOURNAL ARTICLE
Ze-Gui Huang, Jing-Wei Gao, Zhi-Teng Chen, Hai-Feng Zhang, Si You, Zhuo-Chao Xiong, Yu-Biao Wu, Qing-Yuan Gao, Jing-Feng Wang, Yang-Xin Chen, Shao-Ling Zhang, Pin-Ming Liu
OBJECTIVE: The impact of comprehensive risk factor control on heart failure (HF) risk and HF-free survival time in individuals with type 2 diabetes (T2D) was evaluated in this study. RESEARCH DESIGN AND METHODS: This prospective study included 11,949 individuals diagnosed with T2D, matched with 47,796 non-T2D control study participants from the UK Biobank cohort. The degree of comprehensive risk factor control was assessed on the basis of the major cardiovascular risk factors, including blood pressure, BMI, LDL cholesterol, hemoglobin A1c, renal function, smoking, diet, and physical activity...
August 13, 2024: Diabetes Care
#18
JOURNAL ARTICLE
Olga A Khavjou, Minglu Sun, Sophia R D'Angelo, Simon J Neuwahl, Thomas J Hoerger, Pyone Cho, Kristopher Myers, Ping Zhang
OBJECTIVE: To update state-specific estimates of diabetes-attributable costs in the U.S. and assess changes in spending from 2013 to 2021. RESEARCH DESIGN AND METHODS: We used an attributable fraction approach to estimate direct medical costs of diagnosed diabetes using the 2021 State Health Expenditure Accounts, the 2021 Behavioral Risk Factor Surveillance System, and the Centers for Medicare and Medicaid Services 2018-2019 Minimum Data Set. We estimated diabetes-attributable productivity losses from morbidity and mortality using the 2016-2021 National Health Interview Survey and the 2021 mortality data from the Centers for Disease Control and Prevention...
August 9, 2024: Diabetes Care
#19
JOURNAL ARTICLE
Nooria Atta, Anuli Ezeoke, Clive J Petry, Laura C Kusinski, Claire L Meek
OBJECTIVE: The increased risk of pregnancy complications in type 1 diabetes is mainly attributed to maternal hyperglycemia. However, it is unclear whether other potentially modifiable factors also contribute to risk in this population. We sought to assess whether high BMI and excessive gestational weight gain (GWG) are associated with perinatal complications in type 1 diabetes. RESEARCH DESIGN AND METHODS: We searched Medline, Embase, PubMed, Scopus, Web of Science, and Cochrane databases to January 2024...
August 7, 2024: Diabetes Care
#20
JOURNAL ARTICLE
Faisal S Malik, Tom Chen, Maria Manzueta, Joyce P Yi-Frazier, Catherine Pihoker, Jessica L LeBlanc, Seema K Shah, Davene R Wright
OBJECTIVE: To evaluate whether financial incentives lead to improvement in self-management behaviors and glycemia in adolescents with type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: Adolescents (12- to 18-year-olds) with T1D selected incentivized self-management behavior and clinical outcome goals in a 3-treatment (gain frame, loss frame, no incentives) crossover randomized controlled trial. Participants could earn up to $180 in each 12-week incentive treatment arm...
August 7, 2024: Diabetes Care
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
